Jyh-Haur Woo1, Marcus Ang1, Hla Myint Htoon2, Donald Tan3. 1. Singapore National Eye Centre, Singapore; Singapore Eye Research Institute, Singapore; Duke-National University of Singapore (NUS) Medical School, Singapore. 2. Singapore Eye Research Institute, Singapore; Duke-National University of Singapore (NUS) Medical School, Singapore. 3. Singapore National Eye Centre, Singapore; Singapore Eye Research Institute, Singapore; Duke-National University of Singapore (NUS) Medical School, Singapore. Electronic address: donald.tan.t.h@singhealth.com.sg.
Abstract
PURPOSE: To compare the long-term graft survival outcomes and complications of patients who underwent Descemet membrane endothelial keratoplasty (DMEK), Descemet stripping automated endothelial keratoplasty (DSAEK), and penetrating keratoplasty (PK) for Fuchs endothelial corneal dystrophy (FECD) and bullous keratopathy (BK). DESIGN: Retrospective comparative cohort study. METHODS: Patients with FECD and BK who underwent DMEK (121 eyes), DSAEK (423 eyes), or PK (405 eyes) from the prospective cohort from the Singapore Corneal Transplant Registry were included. A Kaplan-Meier survival analysis was conducted to compare the survival probabilities of the 3 groups. The main outcome measure was graft survival. RESULTS: The DMEK group had the best overall cumulative graft survival of 97.4%, compared to DSAEK (78.4%) and PK (54.6%) (P < .001). In eyes with FECD, the DMEK group had the best graft survival of 98.7% compared to DSAEK (96.2%) and PK (73.5%) (P = .009). The graft survival in eyes with BK was poorer overall; however, the DMEK group still had the best graft survival of 94.7%, compared to DSAEK (65.1%) and PK (47.0%, P = .001). Eyes that underwent DMEK had the lowest rate of graft rejection (1.7% vs DSAEK 5.0% vs PK 14.1%, P < .001) and postoperative elevation of intraocular pressure (11.6% vs DSAEK 23.6% vs PK 22.5%, P = .015). CONCLUSIONS: Patients who underwent DMEK for FECD and BK had better graft survival compared to DSAEK and PK. Eyes that underwent DMEK also had a significantly lower rate of graft rejection and elevated intraocular pressure compared to DSAEK and PK for the same indications.
PURPOSE: To compare the long-term graft survival outcomes and complications of patients who underwent Descemet membrane endothelial keratoplasty (DMEK), Descemet stripping automated endothelial keratoplasty (DSAEK), and penetrating keratoplasty (PK) for Fuchs endothelial corneal dystrophy (FECD) and bullous keratopathy (BK). DESIGN: Retrospective comparative cohort study. METHODS:Patients with FECD and BK who underwent DMEK (121 eyes), DSAEK (423 eyes), or PK (405 eyes) from the prospective cohort from the Singapore Corneal Transplant Registry were included. A Kaplan-Meier survival analysis was conducted to compare the survival probabilities of the 3 groups. The main outcome measure was graft survival. RESULTS: The DMEK group had the best overall cumulative graft survival of 97.4%, compared to DSAEK (78.4%) and PK (54.6%) (P < .001). In eyes with FECD, the DMEK group had the best graft survival of 98.7% compared to DSAEK (96.2%) and PK (73.5%) (P = .009). The graft survival in eyes with BK was poorer overall; however, the DMEK group still had the best graft survival of 94.7%, compared to DSAEK (65.1%) and PK (47.0%, P = .001). Eyes that underwent DMEK had the lowest rate of graft rejection (1.7% vs DSAEK 5.0% vs PK 14.1%, P < .001) and postoperative elevation of intraocular pressure (11.6% vs DSAEK 23.6% vs PK 22.5%, P = .015). CONCLUSIONS:Patients who underwent DMEK for FECD and BK had better graft survival compared to DSAEK and PK. Eyes that underwent DMEK also had a significantly lower rate of graft rejection and elevated intraocular pressure compared to DSAEK and PK for the same indications.
Authors: Katja C Iselin; Emily Greenan; Colin Hynes; Sandra Shaw; Tim Fulcher; William J Power; Barry Quill; Marc Guerin; Weng H Lee; Conor C Murphy Journal: Ir J Med Sci Date: 2020-09-04 Impact factor: 1.568
Authors: Xinwen Yao; Kavya Devarajan; René M Werkmeister; Valentin Aranha Dos Santos; Marcus Ang; Anthony Kuo; Damon W K Wong; Jacqueline Chua; Bingyao Tan; Veluchamy Amutha Barathi; Leopold Schmetterer Journal: Biomed Opt Express Date: 2019-10-11 Impact factor: 3.732
Authors: Francesco Aiello; Federico Genzano Besso; Giulio Pocobelli; Gabriele Gallo Afflitto; Rossella Anna Maria Colabelli Gisoldi; Carlo Nucci; Diego Ponzin Journal: Cell Tissue Bank Date: 2021-05-24 Impact factor: 1.522